Ethnicity Bias and the Diagnosis of Schizophrenia

Stephen Strakowski, M.D.

Introduction

Stephen M. Strakowski, MD, is the Founding Chair of Psychiatry and the Interim Director of the Mulva Clinic for the Neurosciences at the Dell Medical School, University of Texas in Austin. He is also Professor of Psychiatry, Psychology, and Educational Psychology at UT. Previously, he spent 24 years at the University of Cincinnati/UC Health where he served as Senior Vice President of Strategy and Transformation in UC Health (the health system associated with University of Cincinnati) and Professor of Psychiatry and Behavioral Neuroscience, Psychology and Biomedical Engineering among other roles.  Dr. Strakowski graduated summa cum laude from the University of Notre Dame with a BSE in 1984, and alpha omega alpha from Vanderbilt University School of Medicine with an MD in 1988.  He completed his residency training at McLean Hospital/Harvard University School of Medicine in 1992.  Upon completing residency, he moved to the University of Cincinnati as an Assistant Professor, where he has been promoted to his current positions. Dr. Strakowski is an internationally recognized and trusted expert in the study and treatment of bipolar and other mood disorders.  His research group has been a world leader studying the treatment, outcomes and neurobiology of these conditions.  His group has also lead investigation of how patient ethnicity impacts psychiatric diagnosis.  He is recognized as a Best Doctor® and by US News and World Report® as a Top 1% Psychiatrist.  He maintains an active clinical practice and research career for the Veteran’s Administration, and Women’s Center of Excellence for Specialty Care.  His research activities include projects related to mental health help seeking, culturally centered integrated care, and integration of mental health in diverse settings.  His work has been presented at national and international conferences, and he has published numerous articles in peer-reviewed journals, and is a sought after public speaker and mental health policy consultant.

Learning Objectives

1. Describe how a patient's race/ethnicity impacts psychiatric diagnoses.
2. Identify approaches toward minimizing race/ethnicity bias in the diagnosis of schizophrenia.
3. Apply the discussions of this talk to minimize bias in clinical practices.

 
Live webcast available at:  http://videos.mayo.edu/live
1 AMA PRA Category 1 Credit(s)™ hour is offered for watching this Webcast live.  Ethos will be implemented for all post presentation surveys.  To document your attendance, please text the code given at the presentation to 507-200-3010.  For questions, email rstpsychgr@mayo.edu.

Credit Statements

• In support of improving patient care, Mayo Clinic College of Medicine and Science is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
• Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. 
• The Department of Psychiatry and Psychology at Mayo Clinic, Rochester, is approved by the American Psychological Association to sponsor continuing education credits for psychologists. The Department of Psychiatry and Psychology at Mayo Clinic, Rochester maintains responsibility for this program and its content. 
• Archived webcast available at: Psychiatry & Psychology Video Library

Industry Acknowledgment (if applicable): None.

NEW in 2017 !!!

All participants MUST complete the evaluation in order to get CME or APA Credit. 

1) Text the CODE announced at the session within 48 hours to (507) 200-3010
2) Login at ce.mayo.edu and go to My Account, My Courses, Registered Courses, click Session title and START to access the required Evaluation.
-or-
Click the START button on that session page.
3) Evaluation must be completed within 2 weeks.
 
Disclosure Summary
As a Jointly Accredited Provider by ACCME, ACPE, and ANCC, Mayo Clinic College of Medicine and Science must ensure balance, independence, objectivity and scientific rigor in its educational activities. Course Director(s), Planning Committee Members, Faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity.  Safeguards against commercial bias have been put in place.  Faculty also will disclose any off label and/or investigational use of pharmaceuticals or instruments discussed in their presentation.  Disclosure of these relevant financial relationships will be published in activity materials so those participants in the activity may formulate their own judgments regarding the presentation.

Listed below are individuals with control of the content of this program who have disclosed…

Relevant financial relationship(s) with industry:

Mark Frye, M.D., Mayo Clinic           

Grant Support:  AssureRx, Janssen R&D, Myriad, PfizerConsultant:  Janssen R&D, Mitsubishi Tanabe Pharma Corp., Myriad Genetics, Sunovion, Supernus Pharmaceuticals, Teva Pharmaceuticals, Neuralstem, Inc.

CME/Travel:  American Physician Institute, CME Outfitters

Stephen Strakowski, M.D.(Speaker):  Consultant:  Sunovion (Chair of DSMBs); Grant Research Support:  Janssen, Otsuka (both through UT)

No relevant financial relationship(s) with industry:
Mark Frye, M.D., Kriti Gandhi, M.D., Allison Holgerson, Ph.D., Matej Markota, M.D., Charlene Nelson, Reem Shafi, M.B.B.S., Larua Suarez, M.D.

References to off-label usage(s) of pharmaceuticals or instruments in their presentation:  NONE